| dbo:abstract
|
- ADB-BINACA is a cannabinoid designer drug that has been found as an ingredient in some synthetic cannabis products. It was originally developed by Pfizer as a potential analgesic, and is a potent agonist of the CB1 receptor with a binding affinity (Ki) of 0.33 nM and an EC50 of 14.7 nM. (en)
|
| dbo:casNumber
|
- 1185282-27-2
- 2682867-55-4
|
| dbo:fdaUniiCode
| |
| dbo:pubchem
| |
| dbo:thumbnail
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 7599 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:c
|
- 18 (xsd:integer)
- 21 (xsd:integer)
|
| dbp:casNumber
|
- 1185282 (xsd:integer)
- 2682867 (xsd:integer)
|
| dbp:chemspiderid
|
- 57621565 (xsd:integer)
- 81407832 (xsd:integer)
|
| dbp:drugName
| |
| dbp:h
|
- 24 (xsd:integer)
- 26 (xsd:integer)
|
| dbp:iupacName
|
- N-[-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-benzyl-1H-indazole-3-carboxamide (en)
- N-[-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-butyl-1H-indazole-3-carboxamide (en)
|
| dbp:legalCa
| |
| dbp:legalDe
| |
| dbp:legalUk
| |
| dbp:legalUs
| |
| dbp:n
| |
| dbp:o
| |
| dbp:pubchem
|
- 129406620 (xsd:integer)
- 155907792 (xsd:integer)
|
| dbp:smiles
|
- O=CC1=NNC2=C1C=CC=C2 (en)
- O=CC1=NNC3=C1C=CC=C3 (en)
|
| dbp:stdinchi
| |
| dbp:stdinchikey
|
- GPWADXHYJAZPAX-OAHLLOKOSA-N (en)
- IUFIUAWRCUVUCQ-UHFFFAOYSA-N (en)
|
| dbp:unii
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- ADB-BINACA is a cannabinoid designer drug that has been found as an ingredient in some synthetic cannabis products. It was originally developed by Pfizer as a potential analgesic, and is a potent agonist of the CB1 receptor with a binding affinity (Ki) of 0.33 nM and an EC50 of 14.7 nM. (en)
|
| rdfs:label
| |
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
| |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
